EMA Committee For Medicinal Products For Human Use Adopts Opinion Recommending Authorization Of Moderna's Updated Covid-19 Vaccine In The European Union
Portfolio Pulse from Benzinga Newsdesk
The EMA Committee for Medicinal Products for Human Use has recommended the authorization of Moderna's updated COVID-19 vaccine in the European Union. The vaccine has shown an 8.7 to 11-fold increase in neutralizing antibodies against circulating variants in clinical trials.
September 14, 2023 | 2:23 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Moderna's updated COVID-19 vaccine has been recommended for authorization by the EMA, which could potentially increase the company's market share in the EU.
The recommendation for authorization of Moderna's updated COVID-19 vaccine by the EMA is a positive development for the company. If authorized, it could lead to increased sales and market share in the European Union, positively impacting the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100